ArticleRespiratory medicine case reports2026

Adverse effects of vanzacaftor-tezacaftor-deutivacaftor in a cystic fibrosis population: A case series.

Jordan Saag et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.